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Endovascular Repair for Thoracic Aortic
Pathologies—Early and Midterm Results
Albert C.W. Ting, Stephen W.K. Cheng, Pei Ho, Yiu Che Chan, Jensen T.C. Poon and Grace C.Y. Cheung,
Division of Vascular Surgery, Department of Surgery, University of Hong Kong Medical Centre, 
Queen Mary Hospital, Hong Kong, China.
OBJECTIVE: To assess the early and midterm results of endovascular stent graft repair in patients with
thoracic aortic pathologies.
METHODS: Between March 2000 and December 2005, 44 consecutive patients undergoing endovascular
repair for 45 thoracic aortic lesions were studied. Follow-up protocol includes regular clinical examination
and computed tomographies.
RESULTS: There were 37 men and 7 women with a median age of 59 years at operation (range, 26–90).
The pathologies consisted of 15 thoracic aortic aneurysms, nine pseudoaneurysms, 16 thoracic aortic
dissections, and five thoracic aortic injuries. Successful deployment of the endovascular stent grafts with
complete sealing of the pathology were achieved in all but one patient who had the procedure abandoned
as a result of access difficulty, giving a technical success of 98%. The median hospital stay was 7 days
(range, 3–196), with no hospital death nor paraplegia. The median follow-up was 25 months (range,
0–86). There were eight follow-up deaths, two of which were thoracic aortic pathology related (both
patients had aortoesophageal fistulae). There were three other clinical failures: distal attachment
endoleak in a patient with thoracic aortic aneurysm, one enlarging and one newly developed dissecting
thoracic aortic aneurysm despite endografting. The cumulative freedom from clinical failure and failure
free survival were 90% and 75% at 18 months respectively.
CONCLUSION: Endovascular stent graft repair is a feasible option in thoracic aortic pathologies with
promising early and midterm results. [Asian J Surg 2009;32(1):39–46]
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Introduction
Thoracic aortic diseases carry a high surgical risk. A mor-
tality of 6–69% has been reported for graft replacement in
acute Type B thoracic aortic dissection,1 while thoracic
aortic aneurysm repair also carries significant risk with
an operative mortality of 15.1% reported recently.2 This is
the result of the magnitude of surgery which typically
involves open thoracotomy, extracorporeal circulation
and aortic cross-clamping in a group of patients with
multiple coexisting medical conditions. Major morbidi-
ties, especially spinal cord ischaemia, are also a concern.
An overall incidence of lower limb paraparesis/paraplegia
of 16% was noted in the Houston experience of more than
1,500 patients with thoracoabdominal aortic repair.3 In
the recent decade, endovascular stent graft repair has
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been introduced as a less invasive alternative for treating
abdominal aortic aneurysms, with a reduced periopera-
tive mortality and morbidity.4,5 This treatment strategy
has also been extended to various thoracic aortic patholo-
gies including aneurysm,6,7 pseudoaneurysm,8 dissec-
tion7,9 and trauma.10
Endovascular repair has been our preferred treatment
for thoracic aortic diseases. We aimed to assess the early
and midterm results of this approach.
Patients and methods
Between March 2000 and December 2005, 44 consecutive
patients with 45 thoracic aortic lesions underwent
endovascular stent graft repair after obtaining informed
consent. One patient had two synchronous infected tho-
racic aortic pseudoaneurysms. All the procedures were
performed in the operation theatre, with the image guid-
ance of a mobile C-arm Philips BV-29 (Philips Medical
System, The Netherlands) or OEC 9800 (General Electric
Company, Fairfield, CT). In patients with inadequate
proximal landing zones (< 2 cm), intentional coverage of
the origins of left subclavian arteries were carried out
without prior revascularisation. Further surgical de-
branching of the aortic arch was carried out if necessary.
An endograft with 10–20% oversizing of the landing zone
was selected. Postoperatively, patients were assessed regu-
larly with clinical examination and follow-up computed
tomography (CT) was performed 1 month postopera-
tively as well as every 6 months in the first 2 years and at
least yearly thereafter. The demographic data, periopera-
tive details and follow-up data were prospectively collected.
Cumulative data on clinical failure and the failure free
survival were evaluated with Kaplan-Meier analyses.
Results
There were 37 men and 7 women with a median age of 59
years at operation (range, 26–90 years). One procedure for
a small thoracic aortic aneurysm in an 81-year-old lady
was abandoned due to access difficulties and the patient
did not consent to an iliac conduit. Deployment of the
endovascular stent grafts with successful sealing of the
aneurysm/pseudoaneurysm or aortic tear/injury were
achieved in all the other patients giving a primary techni-
cal success of 98%. The patient comorbidities and the
details of the pathology are listed in Table 1.
Pathologies
Two patients had leaking thoracic aortic aneurysms. All
the thoracic aortic pseudoaneurysms were due to infec-
tion except one that was an anastomotic pseudoaneurysm
which developed after a previous thoracic aortic interpo-
sition graft for aneurysm repair. Three of these patients
presented with massive haematemesis: due to aorto-
esophageal fistulae in two patients, with advanced carci-
noma of the oesophagus in one and primary mycotic
thoracic aortic pseudoaneurysm in the other, and as a
result of aortojejunal fistula complicating anastomotic
leakage in another patient with jejunal interposition after
resection for carcinoma of the oesophagus. One patient
had two synchronous infected aortic pseudoaneurysms
operated on at the same setting. In the 16 patients with
thoracic aortic dissection, two had localised dissection
while the others had typical Type B thoracic aortic dissec-
tion involving the whole descending thoracic aorta. Seven
patients were operated on within 6 weeks of diagnosis for
persistent symptoms, including one with a leaking tho-
racic aortic dissection. The remaining nine patients were
chronic dissections (three patients with aneurysmal
Table 1. Patient comorbidities and the pathology of the 
44 patients with thoracic aortic diseases
n= 44
Comorbidities
Smoker 17
Hypertension 28
Diabetes mellitus 4
Cardiac diseases 15
Stroke 2
Renal impairment 12
ASA class
I 1
II 16
III 19
IV 7
V 1
Pathology
Aneurysm 15
Pseudoaneurysm 9*
Dissection 16
Trauma 5
*One patient had two concomitant thoracic aortic pseudoaneurysms.
ASA = American Society of Anesthesiologists.
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degeneration and six patients with persistent false lumens
and compromised true lumens). Another five patients
sustained blunt trauma with thoracic aortic injuries.
Perioperative details
The perioperative details are shown in Table 2. Concom-
itant open procedures were required in nine patients,
including four iliac conduits for access (all in female pa-
tients), two concomitant open abdominal aortic aneurysm
repairs, and three hybrid procedures with surgical de-
branching of the aortic arch in order to secure adequate
proximal landing zones. The origins of the left subclavian
arteries were covered intentionally in 15 patients (35%)
without prior revascularisation. Additional bare metal,
self-expanding Z-stents (Cook, Bloomington, IN, USA)
were put into the true lumen distal to the endografts in
six patients with thoracic aortic dissection, with an aim of
supporting the true lumen and stabilising the dissection
flap. The secondary re-entry tears were left undisturbed
in the patients with aortic dissection.
Intraoperative angiograms showed successful exclu-
sion of the pathologies in all patients. Blood loss was
mainly from valves of the deployment sheaths. Eight
patients (19%) required blood transfusion, including 
one requiring 12 units of blood as a result of an intra-
operative anastomotic dehiscence in a patient undergoing
surgical de-branching of the aortic arch with ascending
aorta to innominate/left common carotid bypass.
All patients were discharged alive with no hospital
mortality. The median hospital stay was 7 days (range,
3–196). A patient with thoracic aortic injury (attempted
suicide by jumping from height) stayed in the hospital for
more than 6 months due to severe concomitant brain
injury. Complications occurred in seven patients (16%),
including cardiac arrhythmia in four, pneumonia in two,
and one each of congestive heart failure, groin wound
infection, pseudomembranous colitis and acute cholangi-
tis. The patient with thoracic aortic injury after attempted
suicide also developed acute renal failure requiring per-
manent renal replacement therapy. There was no paraple-
gia nor a neurological deficit as a consequence of spinal
ischaemia or coverage of the left subclavian arteries.
Follow-up
The median follow-up was 25 months (range, 0–86).
There were eight follow-up deaths, including two patients
with aortoesophageal fistulae where the fistula tracts
were persistent, three patients with terminal malignancy
and one patient each with myocardial infarction, pneu-
monia and massive stroke. There were three other clinical
failures apart from the two patients with aortoesophageal
fistulae; one patient with thoracic aortic aneurysm who
developed a distal attachment endoleak, one patient with
an enlarging aneurysm sac and one with a newly devel-
oped dissecting thoracic aortic aneurysm despite endo-
grafting. The cumulative rate of freedom from clinical
failure was 90% at 18 months while that for failure free
survival was 75% at 18 months.
Aneurysm
With a median follow-up of 21 months (range, 2–71),
there were two deaths (one from carcinoma of the lung
and the other from myocardial infarction). The aneurysm
sacs were well thrombosed except in an 84-year-old man
who developed a distal attachment endoleak on follow-
up as a result of an inadequate distal landing zone. The
patient declined further intervention. Ten aneurysm sacs
(71%) decreased in size (median of decrease, 10 mm;
Table 2. Perioperative details of the 43 patients with successful
deployment of endografts
Median (range)
Anaesthesia (local:general) 4:39
Operating time (min) 150 (60–480)
Duration of image intensifier (min) 8.8 (2.5–23.5)
Contrast used (mL) 120 (40–250)
Blood loss (mL) 150 (50–3,500)
Need for transfusion 8
Volume of blood transfusion (mL) 0 (0–3,600)
Need for ICU stay 25
ICU stay (d) 1 (0–23)
Hospital stay (d) 7 (3–196)
Types of stent graft deployed
AneuRx 3
Talent 10*
Zenith 25
Excluder 3
*One patient had two concomitant thoracic aortic pseudo-
aneurysms treated with Talent grafts. ICU = intensive care unit;
AneuRx = Medtronic AVE Inc., Santa Rosa, CA; Talent = Medtronic
AVE Inc., Santa Rosa, CA; Zenith = Cook, Bloomington, IN; Excluder =
WL Gore, Flagstaff, AZ.
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range, 1–28 mm), with the majority (90%) showing a 
significant reduction (≥ 5 mm) (Figure 1).
Pseudoaneurysm
With a median follow-up of 17 months (range, 3–56), there
were four follow-up deaths. Two patients had persistent
oesophageal contamination to the stent grafts and they
died of graft infection and haematemesis 3 months after
the initial stent graft placement. The other two patients
died of pneumonia and massive stroke respectively. The
three remaining patients with infected thoracic aortic
pseudoaneurysms were all kept on life-long maintenance
oral antibiotics according to the culture results with con-
sultation to the microbiologist. They remained well with
no evidence of graft infection at follow-up 56 months, 
54 months, and 52 months after the operation respec-
tively. Follow-up CT was performed on each patient, with
no evidence of late graft infection detected. Thrombosis
of the pseudoaneurysm sacs with a significant reduction
in sac size (≥ 5 mm) was also noted in all patients with
infected pseudoaneurysms who had a follow-up of more
than 6 months including the two patients who died of
pneumonia and stroke (Figure 2). The other patient with
an anastomotic pseudoaneurysm also had complete throm-
bosis of the sac although the sac size remained static.
Dissection
With a median follow-up 26 months (range, 13–86) there
were two deaths from malignancy. Eleven patients (69%)
had the thoracic aortic false lumen at the stented region
completely healed (Figure 3), including the two patients
with localised dissections. Two other patients had only
partial thrombosis of the false lumen. One of them had a
tear into the false lumen at the distal stent graft attachment
A B
Figure 1. Computed tomographies showing decreasing size of the aneurysm sac after endovascular stent graft repair: (A) preoperative;
(B) 4 years after operation. Note the complete thrombosis of the sac with no endoleak.
A B
Figure 2. Computed tomographies showing an infected thoracic aortic pseudoaneurysm with complete thrombosis of the sac after
endovascular repair: (A) preoperative; (B) 6 months after operation.
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site with subsequent aneurysmal degeneration. Additional
distal stent graft to cover the tear was planned. In the
remaining three patients who presented with aneurysmal
degeneration, the false lumen thrombosed completely in
two with significant decrease in the size of the dissecting
aneurysms (> 10 mm). In one patient with a dissecting
aneurysm over the lower thoracic aorta, the false lumen
remained patent due to the distal secondary tear result-
ing in continued increasing size of the aneurysm despite
successful coverage of the primary tear at the proximal
descending aorta. Open conversion was arranged. Second-
ary re-entry tears were left undisturbed resulting in per-
sistent false lumens in the abdominal aorta in the majority
of patients (81%). Endovascular coiling was required in
one patient with endoleak from retrograde flow of the left
subclavian artery.
Trauma
All the five patients with thoracic trauma were alive at a
median follow-up of 32 months (range, 0–65). One
patient, being a tourist, went back to his home country
and did not attend follow-up. CT before his discharge
showed healing of the aortic injury. The other four
patients were alive with healed aortic disruption although
one of the patients was institutionalised because of severe
concomitant brain injury. Figure 4 shows the CT and
intraoperative angiograms before and after endovascular
stent graft repair in a patient with thoracic aortic injury.
Discussion
Endovascular stent graft repair appears to be a safe option
in patients with thoracic aortic pathologies as judged by
the zero hospital mortality in this group of 44 consecutive
patients. It obviated the need for thoracotomy, significant
blood loss, aortic cross-clamping, and extra-corporeal cir-
culation in these patients with multiple concomitant medi-
cal comorbidities, where a large proportion (61%) had an
ASA (American Society of Anesthesiologists) classification
III or above. Our early results compare favourably with that
from the largest series of thoracic endografting reported
by the EUROSTAR and UK Thoracic Endograft Registries,
where an overall 30-day mortality of 9.3% and a paraple-
gia/paraparesis rate of 2.5% were noted.11 Apart from
A
C
B
Figure 3. Serial computed tomographies showing complete healing
of the thoracic aortic dissection in a patient 18 months after
endovascular repair: (A) preoperative; (B) 1 month after operation;
(C) 18 months after operation.
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being immediately life-saving for the patients with leaking
aneurysms or aortic disruptions, the midterm results are
also promising as there were only two aortic pathology-
related mortalities at a median follow-up of 25 months.
The two patients with aortoesophageal fistulae died 3
months after endografting. Their demises were not unex-
pected given the persistent oesophageal contamination as
a result of the lack of definitive surgery. The cumulative
clinical success, i.e. freedom from clinical failure such as
attachment leaks, sac enlargement etc., was also remark-
able with 90% at 18 months.
Traditionally, medical management has been the stan-
dard for uncomplicated Type B thoracic aortic dissection
because of the high risk of open repair. Nevertheless, with
medical therapy, the mortality still reached 20%12 with
more than 30% developed aneurysmal changes at 3-year
follow-up.13 The concept of endovascular stent graft re-
pair appears appealing as it achieves the goal of surgical
treatment by covering the aortic tear and thus depres-
surising the false lumen. It induces false lumen thrombo-
sis and remodelling with “healing” of the aorta, as well as
enlargement of the true lumen. Such an approach may
effectively treat malperfusion syndrome (at least those
caused by dynamic obstruction), and theoretically reduce
late aortic-related complications by minimising the 
incidence of aneurysmal degeneration.1 In the landmark
study reported by Dake in 1999, 19 patients with thoracic
aortic dissection were treated by endovascular means with
a 100% technical success and complete false lumen throm-
bosis achieved in 79%.9 We showed a similarly promising
result with 69% of the thoracic false lumen healed at a
median follow-up of 26 months, although there were two
A B
C D
Figure 4. Computed tomographies and intra-operative angiograms showing the typical aortic disruption (arrow) in a patient sus-
taining deceleration injury. Complete sealing of the tear was achieved after endografting: (A) preoperative computed tomography;
(B) intra-operative angiogram showing the aortic disruption; (C) computed tomography 1 month after repair showing complete
healing of the aortic disruption; (D) intra-operative angiogram showing complete sealing of the aortic tear after endografting.
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clinical failures. There was a new aneurysmal degenera-
tion developed in a patient who had only partial throm-
bosis of the false lumen as a result of a tear into the false
lumen at the distal landing zone and there was another
patient with a patent false lumen at the distal thoracic
aorta with increasing size of the dissecting aneurysm. In a
recent report comparing medical treatment with endovas-
cular repair for Type B thoracic dissection, aneurysmal
dilatation of the descending thoracic aorta was much more
frequent in those with medical therapy (28.5% vs. 3.5%).14
Most patients still had patent secondary re-entry tears
resulting in persistent false lumen in the abdominal
aorta. Some believe that this may not necessarily be detri-
mental because, unlike the thoracic segment, the abdom-
inal false lumen does not appear to have a propensity for
aneurysmal dilatation.15 However, as noted in our patient
with distal dissecting thoracic aortic aneurysm, contin-
ued perfusion of the lower thoracic false lumen may occur
as a result of the distal secondary tear, leading to contin-
ued increasing size of the dissecting aneurysm despite
coverage of the primary tear. Further research on this
aspect is required.
Although our current results and those from other
reports15–17 have shown favourable outcomes in patients
with thoracic aortic dissection receiving endovascular
repair, as with all new therapies, randomized controlled
trials would be the ultimate answer. This would be
addressed by the INSTEAD trial, which compared the
outcome of uncomplicated type B aortic dissection when
treated by endovascular stent grafting adjunctive to best
medical treatment versus best medical treatment alone.18
Preliminary trial results, however, showed no survival
benefit from stent grafting after the first year.19
Endovascular repair for infected aortic pseudo-
aneurysm is more controversial. There has always been a
concern about persistent infection by putting a stent graft
in an infected field. However, even with open repair, in situ
prosthetic reconstruction was often unavoidable. Long
term follow-up (> 50 months) in three of our patients with
four infected aortic pseudoaneurysms showed no clinical
evidence of sepsis with complete exclusion of the
pseudoaneurysms and significant reduction in the sac
size. We believe that potent antibiotics with life-long
maintenance together with regular surveillance using
computed tomographies are indispensable.8
Adequacy of a proximal landing zone (> 2 cm) is al-
ways a concern in endovascular repair of thoracic aortic
pathologies. Intentional coverage of the origins of the left
subclavian artery was required in 15 patients (35%) with
additional aortic arch de-branching performed in three of
them. There were no adverse neurological events. Although
posterior circulation stroke is always a possibility, opinions
diverge about the need for extra-anatomic revascularisa-
tion of the subclavian artery under these circumstances.
There are proponents of routine subclavian revascularisa-
tion when intentional coverage of the left subclavian ori-
gin is required,20,21 while others believe that coverage of
the left subclavian artery is generally well tolerated even
without revascularisation owing to the extensive collateral
blood supply to the arm.22,23 Nienaber from Germany24
advocates a more selective approach and considers revas-
cularisation only in those who develop ischaemic symp-
toms or who have a potentially compromised collateral
circulation as shown in preoperative imaging of the supra-
aortic arteries. Although none of our patients had neuro-
logical events, one patient with thoracic aortic dissection
developed a Type II endoleak via the retrograde flow from
the covered left subclavian artery requiring subsequent
endovascular coiling.
In summary, endovascular stent graft repair is a feasi-
ble option for patients with thoracic aortic pathologies
including aneurysm, pseudoaneurysm, dissection and
trauma, with promising early and midterm results. How-
ever, further confirmation is required by longer follow-
up and the need for continued surveillance cannot be
overemphasised.
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